We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Richard Lafferty has been assisting clients through the H1B Visa process since 2021.

As of 2022, Richard Lafferty has succesfully submitted and recieved certification for 193 cases.

Richard Lafferty is located in New York, NY, and has represented 5 employers for the H1B Visa Process

194
Cases Handled
193
Cases Certified
99.48%
Approval

Cases Handled by Richard Lafferty

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23285-426109 Certified Bioinformatics Scientists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-22143-199864 Certified Bioinformatics Scientists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022
I-200-22083-007476 Certified Bioinformatics Scientists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022
I-200-22081-997005 Certified Bioinformatics Scientists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022
I-200-24346-534100 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2025
I-200-24185-170833 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24159-083313 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24158-077887 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24156-066871 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24115-919338 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024